贝塔抑制剂使用与抑郁症之间的关联 - 叙述性审查
Kamila Tokarczyk1, Karolina Sas1, Magdalena Piegza2
1Studenckie Koło Naukowe, Oddział Kliniczny Psychiatrii Katedry Psychiatrii, Wydział Nauk Medycznych w Zabrzu, Śląski Uniwersytet Medyczny w Katowicach, 42-612 Tarnowskie Góry.
Psychiatria polska
|March 3, 2025
概括
贝塔抑制剂通常不会导致心脏病患者的抑郁症. 虽然美托普罗罗尔可能会使症状恶化,但其他β抑制剂,如卡维迪罗尔,与抑郁症无关.
科学领域:
- 心脏病学 心脏病学
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抑郁症在体质疾病中很常见,恶化心血管健康.
- 贝塔抑制剂广泛用于心血管疾病,引发了人们对潜在情绪副作用的担忧.
研究的目的:
- 分析β抑制剂对抑郁症状的频率和严重性的影响.
- 调查常用的β-阻断剂对情绪的中心和外围影响.
主要方法:
- 对常用β-阻断剂的医学数据的审查.
- 分析的重点是脂友性和中枢神经系统的透.
- 考虑中心和外围的毒品行为.
主要成果:
- 在大多数研究中,甲醇与抑郁症状的增加有关.
- 卡维迪洛尔,比索普罗洛尔和普拉诺洛尔没有诱导抑郁症状.
- 贝塔抑制剂对抑郁症诱导没有显著影响;有些可能会预防它.
- 在减少焦虑方面注意到了积极的影响,以及潜在的疲劳和睡眠障碍.
结论:
- β抑制剂对诱导抑郁症状具有临床上微不足道的影响.
- 特定的β-阻断剂可能提供对抑郁症的保护作用或减少其严重程度.
- β抑制剂可以减轻焦虑,但可能会导致疲劳和睡眠问题.
相关概念视频
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
521
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
521
Antidepressant Drugs: MAOIs and Other Agents
175
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
175
Depression: Overview
206
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
206
Antihypertensive Drugs: Types of β-Blockers
558
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
558
Antidepressant Drugs: Overview
346
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
346
Depressive Disorders: Etiology
27
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
27


